register

Medical and Science

First female president of the Cardiac Society of Australia and New Zealand

Health Industry Hub | August 13, 2019 |

The Cardiac Society of Australia and New Zealand (CSANZ) is pleased to announce the appointment of Professor Clara Chow as President-elect. Clara will be the CSANZ’s first female President, her term in office commencing in August 2020.

Clara Chow is Professor of the Faculty of Medicine and Health at the University of Sydney and is Academic Director of the Westmead Applied Medical Research Centre and Program Director Community Based Cardiac Services and Cardiologist at Westmead Hospital, Sydney.

The Cardiac Society of Australia and New Zealand is the professional body for cardiologists and those working in the area of cardiology including researchers, scientists, cardiovascular nurses, allied health professionals and other healthcare workers. The Society is established with the object of promoting the highest standards of education, training, research and practice in cardiovascular medicine and surgery as well as promoting the prevention and control of cardiovascular disease in human beings.

CSANZ President, Professor Len Kritharides, said “The CSANZ is very fortunate to have Clara as its incoming President. She is an outstanding Cardiologist and Researcher and will bring great energy and insight to the role.”

Professor Chow said “I am excited and proud to take up the President-elect position of the Cardiac Society of Australia and New Zealand. I think this shows the strong commitment of our society to change and addressing the challenges of diversity for our members as well as our patients.”

Prof Chow will serve as President-elect for 12 months and will take up the role of President in August, 2020.

You may also like Therapeutics and the importance of cancer research in Australia


News - Pharmaceuticals

New vaccine guidelines risk further decline in vaccine uptake

New vaccine guidelines risk further decline in immunisation

Health Industry Hub | August 11, 2026 |

The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]

More


News - Pharmaceuticals

The weight of the wait: GLP-1 boom hits PBS roadblock

The weight of the wait: GLP-1 boom hits PBS roadblock

Health Industry Hub | August 11, 2026 |

More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]

More


News - MedTech & Diagnostics

As insurer blame game escalates, patients miss out on the promise of private health

As insurer blame game escalates, patients miss out on the promise of private health

Health Industry Hub | August 11, 2026 |

The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]

More


Leadership & Management

David Henderson appointed Takeda Oceania Country Head

David Henderson appointed Takeda Oceania Country Head

Health Industry Hub | August 10, 2026 |

David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]

More


This content is copyright protected. Please subscribe to gain access.